The movement disorder society criteria : its clinical usefulness in multiple system atrophy

Tarisawa, Monami; Matsushima, Masaaki; Kudo, Akihiko; Sakushima, Ken; Kanatani, Yasuhiro; Nishimoto, Naoki; Sawada, Jun; Matsuoka, Takeshi; Hisahara, Shin; Uesugi, Haruo; Minami, Naoya; Sako, Kazuya; Takei, Asako; Tamakoshi, Akiko; Sato, Norihiro; Sasaki, Hidenao; Yabe, Ichiro

The movement disorder society criteria : its clinical usefulness in multiple system atrophy

Tarisawa, Monami; Matsushima, Masaaki; Kudo, Akihiko et al.

Internal medicine, 2024, 63(21), 2903-2912

Permalink : https://hdl.handle.net/2115/93889

このアイテムのアクセス数:148件（2026-08-24 08:26 集計）

閲覧可能ファイル

ファイル	フォーマット	サイズ	閲覧回数	説明
IM-3275-23-O.R2	pdf	552 KB	71

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権	open access
URI	https://hdl.handle.net/2115/93889
タイトル	The movement disorder society criteria : its clinical usefulness in multiple system atrophy
著者	Tarisawa, Monami ; Matsushima, Masaaki ; Kudo, Akihiko ; Sakushima, Ken ; Kanatani, Yasuhiro ; Nishimoto, Naoki ; Sawada, Jun ; Matsuoka, Takeshi ; Hisahara, Shin ; Uesugi, Haruo ; Minami, Naoya ; Sako, Kazuya ; Takei, Asako ; Tamakoshi, Akiko ; Sato, Norihiro ; Sasaki, Hidenao ; Yabe, Ichiro
著者名 Tarisawa, Monami
著者名 Matsushima, Masaaki
著者名 Kudo, Akihiko
著者名 Sakushima, Ken
著者名 Kanatani, Yasuhiro
著者名 Nishimoto, Naoki
著者名 Sawada, Jun
著者名 Matsuoka, Takeshi
著者名 Hisahara, Shin
著者名 Uesugi, Haruo
著者名 Minami, Naoya
著者名 Sako, Kazuya
著者名 Takei, Asako
e-Rad_Researcher 90236737 著者名 Tamakoshi, Akiko
著者名 Sato, Norihiro
著者名 Sasaki, Hidenao
e-Rad_Researcher 60372273 著者名 Yabe, Ichiro
言語	英語
キーワード	Multiple system atrophy
	Second consensus statement
	The movement disorder society criteria
	Clinical assessment
	Usefulness
	Utility
発行日	2024-03-18
出版者	Japanese society of internal medicine
収録物名	Internal medicine
巻(号)	63(21)
ページ	2903-2912
抄録	Objective In 2022, Wenning et al. proposed the Movement Disorder Society Criteria (MDS criteria) for the Diagnosis of Multiple System Atrophy (MSA). These criteria were expected to provide useful alternatives to the second consensus statement. We examined trends in these diagnostic criteria.Methods We used patient data registered with the Hokkaido Rare Disease Consortium for Multiple System Atrophy, which has been recruiting patients with MSA through medical facilities in Hokkaido since November 2014. Patients were evaluated according to the MDS criteria based on neurological examinations and imaging findings at three separate times: the first evaluation, the time of enrollment (diagnosis), and the most recent evaluation (final evaluation).Results The MDS criteria were examined in 68 of 244 patients enrolled between November 2014 and July 2022. At the initial evaluation, the classifications were as follows: clinically established (n=27; 39.7%); clinically probable (n=13; 19.1%); possible prodromal (n=12; 17.6%); and negative [did not meet criteria (n=16; 23.5%)]. At the time of diagnosis, the classifications were as follows: clinically established (n=45; 66.2%); clinically probable (n=12; 17.6%); possible prodromal (n=4; 5.9%); and negative (n=7; 10.3%). At the final evaluation, the classifications were as follows: clinically established (n=52; 76.5%); clinically probable (n=9; 13.2%); possible prodromal (n=2; 2.9%); and negative (n=5; 7.4%).Conclusion We were able to clarify the changes in the criteria values and transition of patients due to the clarification of imaging and supportive findings in the MDS criteria.
資源タイプ	学術雑誌論文
出版タイプ	Version of Record
権利情報	Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
PISSN	0918-2918
EISSN	1349-7235
関連情報 (isIdenticalTo)	出版社版DOI https://doi.org/10.2169/internalmedicine.3275-23